Markel Group Inc. Has $37.67 Million Stock Position in HCA Healthcare, Inc. $HCA

Markel Group Inc. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 80,680 shares of the company’s stock after purchasing an additional 5,467 shares during the quarter. Markel Group Inc.’s holdings in HCA Healthcare were worth $37,666,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of HCA. Viking Global Investors LP raised its position in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after acquiring an additional 649,058 shares during the last quarter. Danske Bank A S bought a new position in shares of HCA Healthcare during the third quarter worth about $115,530,000. Zurich Insurance Group Ltd FI raised its position in shares of HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after acquiring an additional 262,912 shares during the last quarter. Finally, Mondrian Investment Partners LTD bought a new position in shares of HCA Healthcare during the third quarter worth about $106,605,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the subject of a number of analyst reports. Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Robert W. Baird decreased their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Deutsche Bank Aktiengesellschaft decreased their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. The Goldman Sachs Group raised their target price on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Finally, Barclays decreased their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $394.40 on Friday. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The stock has a 50 day moving average price of $465.16 and a two-hundred day moving average price of $483.61. The stock has a market capitalization of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period last year, the business posted $6.45 EPS. The company’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.